EAM

Exome Asset Management Portfolio holdings

AUM $110M
1-Year Return 24.83%
This Quarter Return
+43.4%
1 Year Return
+24.83%
3 Year Return
5 Year Return
10 Year Return
AUM
$101M
AUM Growth
Cap. Flow
+$101M
Cap. Flow %
100%
Top 10 Hldgs %
42.21%
Holding
52
New
52
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RGLS
51
DELISTED
Regulus Therapeutics
RGLS
$228K 0.23%
+178,404
New +$228K
KNTE
52
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$199K 0.2%
+83,848
New +$199K